Molecular farming on rescue of pharma industry for next generations

References

• Alderborn A, Sundstrom J, Soeria-Atmadja D, et al. (2010). Genetically modified plants for non-food or non-feed purposes: straightforward screening for their appearance in food and feed. Food Chem Toxicol, 48, 453–64
   PubMed Web of Science ®Google Scholar
• Andrianantoandro E. (2014). Next-generation therapeutics. Trends Biotechnol, 32, 431–2
   PubMed Web of Science ®Google Scholar
• Apweiler R, Hermjakob H, Sharon N. (1999). On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta, 1473, 4–8
   PubMed Web of Science ®Google Scholar
• Bardor M, Loutelier-Bourhis C, Paccalet T, et al. (2003). Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. Plant Biotechnol J, 1, 451–62
   PubMed Web of Science ®Google Scholar
• Barta A, Sommergruber K, Thompson D, et al. (1986). The expression of a nopaline synthase – human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Mol Biol, 6, 347–57
   PubMed Web of Science ®Google Scholar
• Basaran P, Rodriguez-Cerezo E. (2008). Plant molecular farming: opportunities and challenges. Crit Rev Biotechnol, 28(3), 153–72
   PubMed Web of Science ®Google Scholar
• Bishop BM. (2015). Potential and emerging treatment options for ebola virus disease. Ann Pharmacother, 49, 196–206
   PubMed Web of Science ®Google Scholar
• Boivin S, Kozak S, Meijers R. (2013). Optimization of protein purification and characterization using Thermofluor screens. Protein Expr Purif, 91, 192–206
   PubMed Web of Science ®Google Scholar
• Boothe J, Nykiforuk C, Shen Y. (2010). Seed-based expression systems for plant molecular farming. Plant Biotechnol J, 8, 588–606
   PubMed Web of Science ®Google Scholar
• Boyhan D, Daniell H. (2011). Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. Plant Biotechnol J, 9, 585–98
   PubMed Web of Science ®Google Scholar
• Buyel JF, Bautista JA, Fischer R, Yusibov VM. (2012). Extraction, purification and characterization of the plant-produced HPV16 subunit vaccine candidate E7 GGG. J Chromatogr B, 880, 19–26
   PubMed Web of Science ®Google Scholar
• Byrne B, Donohoe GG, O'Kennedy R. (2007). Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells. Drug Discov Today, 12, 319–26
   PubMed Web of Science ®Google Scholar
• Capodicasa C, Chiani P, Bromuro C, et al. (2011). Plant production of anti-beta-glucan antibodies for immunotherapy of fungal infections in humans. Plant Biotechnol J, 9, 776–87
   PubMed Web of Science ®Google Scholar
• Castilho A, Strasser R, Stadlmann J, et al. (2010). In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem, 285, 15923–30
   PubMed Web of Science ®Google Scholar
• Chen Q, Lai H, Hurtado J, et al. (2013). Agroinfiltration as an effective and scalable strategy of gene delivery for production of pharmaceutical proteins. Adv Tech Biol Med, 1, 103
   PubMedGoogle Scholar
• Cheung SC, Liu LZ, Lan LL, et al. (2011). Glucose lowering effect of transgenic human insulin-like growth factor-I from rice, in vitro and in vivo studies. BMC Biotechnol, 11, 37
   PubMed Web of Science ®Google Scholar
• Clarke JL, Daniell H, Nugent JM. (2011). Chloroplast biotechnology, genomics and evolution: current status, challenges and future directions. Plant Mol Biol, 76, 207–9
   PubMed Web of Science ®Google Scholar
• Corrado G, Karali M. (2009). Inducible gene expression systems and plant biotechnology. Biotechnol Adv, 27, 733–43
   PubMed Web of Science ®Google Scholar
• Cunha NB, Murad AM, Ramos GL, et al. (2011). Accumulation of functional recombinant human coagulation factor IX in transgenic soybean seeds. Transgenic Res, 20, 841–55
   PubMed Web of Science ®Google Scholar
• D'Aoust MA, Couture MM, Charland N, et al. (2010). The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J, 8, 607–19
   PubMed Web of Science ®Google Scholar
• De Muynck B, Navarre C, Nizet Y, et al. (2009). Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells. Transgenic Res, 18, 467–82
   PubMed Web of Science ®Google Scholar
• Decker EL, Reski R. (2007). Moss bioreactors producing improved biopharmaceuticals. Curr Opin Biotechnol, 18, 393–8
   PubMed Web of Science ®Google Scholar
• Doran PM. (2006). Foreign protein degradation and instability in plants and plant tissue cultures. Trends Biotechnol, 24, 426–32
   PubMed Web of Science ®Google Scholar
• Dus Santos MJ, Wigdorovitz A. (2005). Transgenic plants for the production of veterinary vaccines. Immunol Cell Biol, 83, 229–38
   PubMed Web of Science ®Google Scholar
• Erlendsson LS, Muench MO, Hellman U, et al. (2010). Barley as a green factory for the production of functional Flt3 ligand. Biotechnol J, 5, 163–71
   PubMed Web of Science ®Google Scholar
• Faye L, Boulaflous A, Benchabane M, et al. (2005). Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine, 23, 1770–8
   PubMed Web of Science ®Google Scholar
• Faye L, Gomord V. (2010). Success stories in molecular farming-a brief overview. Plant Biotechnol J, 8, 525–8
   PubMed Web of Science ®Google Scholar
• Fischer R, Schillberg S, Hellwig S, et al. (2012). GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol Adv, 30, 434–9
   PubMed Web of Science ®Google Scholar
• Floss DM, Sack M, Arcalis E, et al. (2009). Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Plant Biotechnol J, 7, 899–913
   PubMed Web of Science ®Google Scholar
• Fong BA, Wu WY, Wood DW. (2009). Optimization of ELP-intein mediated protein purification by salt substitution. Protein Expr Purif, 66, 198–202
   PubMed Web of Science ®Google Scholar
• Frey AD, Karg SR, Kallio PT. (2009). Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Plant Biotechnol J, 7, 33–48
   PubMed Web of Science ®Google Scholar
• Fukuzawa N, Ishihara T, Itchoda N, et al. (2011). Risk-managed production of bioactive recombinant proteins using a novel plant virus vector with a helper plant to complement viral systemic movement. Plant Biotechnol J, 9, 38–49
   PubMed Web of Science ®Google Scholar
• Ge X, Trabbic-Carlson K, Chilkoti A, Filipe CD. (2006). Purification of an elastin-like fusion protein by microfiltration. Biotechnol Bioeng, 95, 424–32
   PubMed Web of Science ®Google Scholar
• Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A. (2012). Production platforms for biotherapeutic glycoproteins: occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng Rev, 28, 147–75
   PubMed Web of Science ®Google Scholar
• Gleba Y, Klimyuk V, Marillonnet S. (2005). Magnifection – a new platform for expressing recombinant vaccines in plants. Vaccine, 23, 2042–8
   PubMed Web of Science ®Google Scholar
• Gomord V, Fitchette AC, Menu-Bouaouiche L, et al. (2010). Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J, 8, 564–87
   PubMed Web of Science ®Google Scholar
• Govea-Alonso DO, Rubio-Infante N, Garcia-Hernandez AL, et al. (2013). Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein. Planta, 4, 785--92
   Google Scholar
• Greco R, Michel M, Guetard D, et al. (2007). Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine, 25, 8228–40
   PubMed Web of Science ®Google Scholar
• Gregory JA, Mayfield SP. (2014). Developing inexpensive malaria vaccines from plants and algae. Appl Microbiol Biotechnol, 5, 1983--90
   Google Scholar
• Guillon S, Tremouillaux-Guiller J, Pati PK, et al. (2006). Hairy root research: recent scenario and exciting prospects – commentary. Curr Opin Plant Biol, 9, 341–6
   PubMed Web of Science ®Google Scholar
• Guzman G, Walmsley A, Webster D, Hamill J. (2011). Hairy roots cultures from different Solanaceous species have varying capacities to produce E. coli B-subunit heat-labile toxin antigen. Biotechnol Lett, 33, 2495–502
   PubMed Web of Science ®Google Scholar
• He X, Galpin JD, Tropak MB, et al. (2012). Production of active human glucocerebrosidase in seeds of Arabidopsis thaliana complex-glycan-deficient (cgl) plants. Glycobiology, 22, 492–503
   PubMed Web of Science ®Google Scholar
• Hefferon K. (2014). Plant virus expression vector development: new perspectives. Biomed Res Into, 2014, 785382
   PubMedGoogle Scholar
• Hernandez-Garcia C, Martinelli A, Bouchard R, Finer J. (2009). A soybean (Glycine max) polyubiquitin promoter gives strong constitutive expression in transgenic soybean. Plant Cell Rep, 28, 837–49
   PubMed Web of Science ®Google Scholar
• Hudson LC, Garg R, Bost KL, Piller KJ. (2014). Soybean seeds: a practical host for the production of functional subunit vaccines. Biomed Res Int, 2014, 340804
   PubMed Web of Science ®Google Scholar
• Huy NX, Yang MS, Kim TG. (2011). Expression of a cholera toxin B subunit-neutralizing epitope of the porcine epidemic diarrhea virus fusion gene in transgenic lettuce (Lactuca sativa L.). Mol Biotechnol, 48, 201–9
   PubMed Web of Science ®Google Scholar
• Jin C, Altmann F, Strasser R, et al. (2008). A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology, 18, 235–41
   PubMed Web of Science ®Google Scholar
• Joensuu JJ, Conley AJ, Linder MB, Menassa R. (2012). Bioseparation of recombinant proteins from plant extract with hydrophobin fusion technology. Methods Mol Biol, 824, 527–34
   PubMedGoogle Scholar
• Kaiser J. (2008). Is the drought over for pharming? Science, 320, 473–5
   PubMed Web of Science ®Google Scholar
• Kim N-S, Kim T-G, Kim O-H, et al. (2008a). Improvement of recombinant hGM-CSF production by suppression of cysteine proteinase gene expression using RNA interference in a transgenic rice culture. Plant Mol Biol, 68, 263–75
   PubMed Web of Science ®Google Scholar
• Kim T-G, Lee H-J, Jang Y-S, et al. (2008b). Co-expression of proteinase inhibitor enhances recombinant human granulocyte–macrophage colony stimulating factor production in transgenic rice cell suspension culture. Protein Expr Purif, 61, 117–21
   PubMed Web of Science ®Google Scholar
• Koprivova A, Stemmer C, Altmann F, et al. (2004). Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol J, 2, 517–23
   PubMed Web of Science ®Google Scholar
• Laguia-Becher M, Martin V, Kraemer M, et al. (2010). Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice. BMC Biotechnol, 10, 52
   PubMed Web of Science ®Google Scholar
• Lau OS, Ng DW, Chan WW, et al. (2010). Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds. Plant Biotechnol J, 8, 994–1004
   PubMed Web of Science ®Google Scholar
• Li W, Li L, Li K, et al. (2011). Expression of biologically active human insulin-like growth factor 1 in Arabidopsis thaliana seeds via oleosin fusion technology. Biotechnol Appl Biochem, 58, 139–46
   PubMed Web of Science ®Google Scholar
• Lico C, Santi L, Twyman RM, et al. (2012). The use of plants for the production of therapeutic human peptides. Plant Cell Rep, 31, 439–51
   PubMed Web of Science ®Google Scholar
• Llop-Tous I, Ortiz M, Torrent M, Ludevid MD. (2011). The expression of a xylanase targeted to ER-protein bodies provides a simple strategy to produce active insoluble enzyme polymers in tobacco plants. PLoS One, 6, e19474
   PubMed Web of Science ®Google Scholar
• Luchakivskaya Y, Kishchenko O, Gerasymenko I, et al. (2011). High-level expression of human interferon alpha-2b in transgenic carrot (Daucus carota L.) plants. Plant Cell Rep, 30, 407–15
   PubMed Web of Science ®Google Scholar
• Ma JK, Barros E, Bock R, et al., C. European Union Framework 6 Pharma-Planta (2005). Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep, 6, 593–9
   PubMed Web of Science ®Google Scholar
• Ma JK, Drake PM, Christou P. (2003). The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet, 4, 794–805
   PubMed Web of Science ®Google Scholar
• Ma S, Jevnikar AM, Hüner NPA. (2011). Microalgae as bioreactors for production of pharmaceutical proteins. Comprehens Biotechnol Second Ed, 4, 301–7
   Google Scholar
• Mayfield SP, Franklin SE, Lerner RA. (2003). Expression and assembly of a fully active antibody in algae. Proc Natl Acad Sci USA, 100, 438–42
   PubMed Web of Science ®Google Scholar
• Meyer DE, Chilkoti A. (1999). Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat Biotechnol, 17, 1112–15
   PubMed Web of Science ®Google Scholar
• Naqvi S, Ramessar K, Farre G, et al. (2011). High-value products from transgenic maize. Biotechnol Adv, 29, 40–53
   PubMed Web of Science ®Google Scholar
• Nopo L, Woffenden BJ, Reed DG, et al. (2012). Super-promoter: TEV, a powerful gene expression system for tobacco hairy roots. Methods Mol Biol, 824, 501–26
   PubMedGoogle Scholar
• Obembe OO, Popoola JO, Leelavathi S, Reddy SV. (2011). Advances in plant molecular farming. Biotechnol Adv, 29, 210–22
   PubMed Web of Science ®Google Scholar
• Oey M, Lohse M, Kreikemeyer B, Bock R. (2009). Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J, 57, 436–45
   PubMed Web of Science ®Google Scholar
• Ortigosa S, Fernández-San Millán A, Veramendi J. (2010). Stable production of peptide antigens in transgenic tobacco chloroplasts by fusion to the p53 tetramerisation domain. Transgenic Res, 19, 703–9
   PubMed Web of Science ®Google Scholar
• Paul M. (2015). International Society for Plant Molecular Farming: 1st Conference, Berlin-Dahlem, Germany, 17th–19th June 2014. Transgenic Res
   Google Scholar
• Paul M, Ma JK. (2011). Plant-made pharmaceuticals: leading products and production platforms. Biotechnol Appl Biochem, 58, 58–67
   PubMed Web of Science ®Google Scholar
• Phan HT, Conrad U. (2011). Membrane-based inverse transition cycling, an improved means for purifying plant-derived recombinant protein-elastin-like polypeptide fusions. Int J Mol Sci, 12, 2808–21
   PubMed Web of Science ®Google Scholar
• Pillay P, Schluter U, van Wyk S, et al. (2014). Proteolysis of recombinant proteins in bioengineered plant cells. Bioengineered, 5, 15–20
   PubMed Web of Science ®Google Scholar
• Pujol M, Gavilondo J, Ayala M, et al. (2007). Fighting cancer with plant-expressed pharmaceuticals. Trends Biotechnol, 25, 455–9
   PubMed Web of Science ®Google Scholar
• Rademacher T, Sack M, Arcalis E, et al. (2008). Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J, 6, 189–201
   PubMed Web of Science ®Google Scholar
• Ramessar K, Sabalza M, Capell T, Christou P. (2008). Maize plants: an ideal production platform for effective and safe molecular pharming. Plant Sci, 174, 409–19
   Web of Science ®Google Scholar
• Rasala BA, Muto M, Lee PA, et al. (2010). Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnol J, 8, 719–33
   PubMed Web of Science ®Google Scholar
• Robert S, Khalf M, Goulet MC, et al. (2013). Protection of recombinant mammalian antibodies from development-dependent proteolysis in leaves of Nicotiana benthamiana. PLoS One, 8, e70203
   PubMed Web of Science ®Google Scholar
• Rosales-Mendoza S, Rubio-Infante N, Zarazua S, et al. (2014). Plant-based vaccines for Alzheimer's disease: an overview. Expert Rev Vaccines, 13, 429–41
   PubMed Web of Science ®Google Scholar
• Rosales-Mendoza S, Soria-Guerra RE, Moreno-Fierros L, et al. (2010). Expression of an immunogenic F1-V fusion protein in lettuce as a plant-based vaccine against plague. Planta, 232, 409–16
   PubMed Web of Science ®Google Scholar
• Ruhlman T, Ahangari R, Devine A, et al. (2007). Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts – oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol J, 5, 495–510
   PubMed Web of Science ®Google Scholar
• Rybicki EP. (2014). Plant-based vaccines against viruses. Virol J, 11, 205
   PubMed Web of Science ®Google Scholar
• Sabalza M, Madeira L, van Dolleweerd C, et al. (2012). Functional characterization of the recombinant HIV-neutralizing monoclonal antibody 2F5 produced in maize seeds. Plant Mol Biol, 80(4–5), 477–88
   PubMed Web of Science ®Google Scholar
• Sabalza M, Vamvaka E, Christou P, Capell T. (2013). Seeds as a production system for molecular pharming applications: status and prospects. Curr Pharm Des, 19, 5543–52
   PubMed Web of Science ®Google Scholar
• Saint-Jore-Dupas C, Faye L, Gomord V. (2007). From planta to pharma with glycosylation in the toolbox. Trends Biotechnol, 25, 317–23
   PubMed Web of Science ®Google Scholar
• Sarrion-Perdigones A, Vazquez-Vilar M, Palaci J, et al. (2013). GoldenBraid 2.0: a comprehensive DNA assembly framework for plant synthetic biology. Plant Physiol, 162, 1618–31
   PubMed Web of Science ®Google Scholar
• Schillberg S, Raven N, Fischer R, et al. (2013). Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures. Curr Pharm Des, 19, 5531–42
   PubMed Web of Science ®Google Scholar
• Schillberg S, Twyman RM, Fischer R. (2005). Opportunities for recombinant antigen and antibody expression in transgenic plants – technology assessment. Vaccine, 23, 1764–9
   PubMed Web of Science ®Google Scholar
• Sharma AK, Sharma MK. (2009). Plants as bioreactors: recent developments and emerging opportunities. Biotechnol Adv, 27, 811–32
   PubMed Web of Science ®Google Scholar
• Shewry PR, Halford NG. (2002). Cereal seed storage proteins: structures, properties and role in grain utilization. J Exp Bot, 53, 947–58
   PubMed Web of Science ®Google Scholar
• Shih SMH, Doran PM. (2009). Foreign protein production using plant cell and organ cultures: advantages and limitations. Biotechnol Adv, 27, 1036–42
   PubMed Web of Science ®Google Scholar
• Sijmons PC, Dekker BM, Schrammeijer B, et al. (1990). Production of correctly processed human serum albumin in transgenic plants. Biotechnology (NY), 8, 217–21
   PubMedGoogle Scholar
• Sourrouille C, Marquet-Blouin E, D'Aoust MA, et al. (2008). Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol J, 6, 702–21
   PubMed Web of Science ®Google Scholar
• Sparrow PA, Twyman RM. (2009). Biosafety, risk assessment and regulation of plant-made pharmaceuticals. Methods Mol Biol, 483, 341–53
   PubMedGoogle Scholar
• Specht E, Miyake-Stoner S, Mayfield S. (2010). Micro-algae come of age as a platform for recombinant protein production. Biotechnol Lett, 32, 1373–83
   PubMed Web of Science ®Google Scholar
• Staub JM, Garcia B, Graves J, et al. (2000). High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat Biotechnol, 18, 333–8
   PubMed Web of Science ®Google Scholar
• Stoger E, Fischer R, Moloney M, Ma JK. (2014). Plant molecular pharming for the treatment of chronic and infectious diseases. Annu Rev Plant Biol, 65, 743–68
   PubMed Web of Science ®Google Scholar
• Stomp AM. (2005). The duckweeds: a valuable plant for biomanufacturing. Biotechnol Annu Rev, 11, 69–99
   PubMedGoogle Scholar
• Streatfield SJ. (2007). Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J, 5, 2–15
   PubMed Web of Science ®Google Scholar
• Sun Q-Y, Ding L-W, Lomonossoff GP, et al. (2011). Improved expression and purification of recombinant human serum albumin from transgenic tobacco suspension culture. J Biotechnol, 155, 164–72
   PubMed Web of Science ®Google Scholar
• Tian L, Sun SS. (2011). A cost-effective ELP-intein coupling system for recombinant protein purification from plant production platform. PLoS One, 6, e24183
   PubMed Web of Science ®Google Scholar
• Tiwari S, Verma PC, Singh PK, Tuli R. (2009). Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv, 27, 449–67
   PubMed Web of Science ®Google Scholar
• Tran M, Van C, Barrera DJ, et al. (2013). Production of unique immunotoxin cancer therapeutics in algal chloroplasts. Proc Natl Acad Sci USA, 110, E15–22
   PubMed Web of Science ®Google Scholar
• Tremblay R, Diao H, Huner N, et al. (2011). The development of a high-yield recombinant protein bioreactor through RNAi induced knockdown of ATP/ADP transporter in Solanum tuberosum. J Biotechnol, 156, 59–66
   PubMed Web of Science ®Google Scholar
• Tzfira T, Citovsky V. (2006). Agrobacterium-mediated genetic transformation of plants, biology and biotechnology. Curr Opin Biotechnol, 17, 147–54
   PubMed Web of Science ®Google Scholar
• Vianna GR, Cunha NB, Murad AM, Rech EL. (2011). Soybeans as bioreactors for biopharmaceuticals and industrial proteins. Genet Mol Res, 10, 1733–752
   PubMed Web of Science ®Google Scholar
• Wakasa Y, Takaiwa F. (2013). The use of rice seeds to produce human pharmaceuticals for oral therapy. Biotechnol J, 8, 1133–43
   PubMed Web of Science ®Google Scholar
• Wang X, Brandsma M, Tremblay R, et al. (2008). A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). BMC Biotechnol, 8, 87
   PubMed Web of Science ®Google Scholar
• Werner S, Breus O, Symonenko Y, et al. (2011). High-level recombinant protein expression in transgenic plants by using a double-inducible viral vector. Proc Natl Acad Sci USA, 108, 14061–6
   PubMed Web of Science ®Google Scholar
• Whaley KJ, Hiatt A, Zeitlin L. (2011). Emerging antibody products and Nicotiana manufacturing. Hum Vaccin, 7, 349–56
   PubMed Web of Science ®Google Scholar
• Wilson IB. (2002). Glycosylation of proteins in plants and invertebrates. Curr Opin Struct Biol, 12, 569–77
   PubMed Web of Science ®Google Scholar
• Wu H, Singh NK, Locy RD, et al. (2004). Expression of immunogenic VP2 protein of infectious bursal disease virus in Arabidopsis thaliana. Biotechnol Lett, 26, 787–92
   PubMed Web of Science ®Google Scholar
• Xu J, Kieliszewski MJ. (2012). A novel plant cell bioproduction platform for high-yield secretion of recombinant proteins. Methods Mol Biol, 824, 483–500
   PubMedGoogle Scholar
• Yusibov V, Streatfield SJ, Kushnir N, et al. (2013). Hybrid viral vectors for vaccine and antibody production in plants. Curr Pharm Des, 19, 5574–86
   PubMed Web of Science ®Google Scholar
• Yusibov V, Streatfield SJ, Kushnir N. (2011). Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin, 7, 313–21
   PubMed Web of Science ®Google Scholar